Clinical trial
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
NCT00044408
Study timeline
Study start (unknown)2002-07-01Date precision: month
Registry last updated2016-07-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetic Neuropathiesunresolved
Diabetes Mellitus, Insulin-Dependentunresolved
Diabetes Mellitus, Non-Insulin-Dependentunresolved
Interventions
Sponsors & collaborators
Chromaderm, Inc.lead sponsor
Mapped research locations
New YorkNew York, United States1BostonMassachusetts, United States1BaltimoreMaryland, United States1TorontoOntario, Canada1San AntonioTexas, United States1MinneapolisMinnesota, United States1VancouverBritish Columbia, Canada1Long BeachCalifornia, United States1ManchesterUnited Kingdom1WinnipegManitoba, Canada1ClearwaterFlorida, United States1HalifaxNova Scotia, Canada1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00044408 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.